A new publication by Prof Martin Widschwendter and his team reports on a test for the detection of uterine cancer that outperforms currently used methods in peri- and postmenopausal women with abnormal vaginal bleeding.
Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.
We are a dynamic and international team with wide range of expertise.